CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 631,176 shares (conversion)
- 4 Conversion Director acquired 77,840 shares (conversion)
- 4 Conversion Director acquired 4,101,800 shares (conversion)
- 4 Conversion Director acquired 77,840 shares (conversion)
- 4 Conversion Director acquired 631,176 shares (conversion)
- 4 Conversion Director acquired 30,459 shares (conversion)
- 4 Open-market buy Director bought 20,000 shares at an average $0.52 ($10,301)
- 4 Conversion Director acquired 314,742 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 2,000 shares at $0.01 ($20)
- 4 Derivatives Options or other derivatives
Page 19 of 29 · 574 filings